CompletedEUCTR 2006-001529-24
Adults adminstered Venlafaxine and Eszopiclone Response to Treatment (AVERT): A 31-Week, Efficacy, Safety and Tolerability Study of Eszopiclone 3 mg Co-administered with Venlafaxine in Subjects wit...
This historical record does not confirm current site availability.
Historical research recordMultiple countriesDepression
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Austria · France and 3 more locations
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- 700
- Sponsor
- Sepracor NV in care of Sepracor Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- France, United Kingdom, Austria, ...
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2006-001529-24
- Official title
Show the full official title
Adults adminstered Venlafaxine and Eszopiclone Response to Treatment (AVERT): A 31-Week, Efficacy, Safety and Tolerability Study of Eszopiclone 3 mg Co-administered with Venlafaxine in Subjects wit...
Get this study by email
Recruitment & locations
CompletedAustria · France · Hungary
2 more locations
- Sweden
- United Kingdom
Registry details
Historical country statuses
- Austria — Completed
- France — Completed
- United Kingdom — Completed
- Hungary — Completed
- Sweden — Completed
Questions about this study
Who is behind this study?
The study sponsor is Sepracor NV in care of Sepracor Inc.
